IMR Press / EJGO / Volume 21 / Issue 3 / pii/2000159

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Endometrial cancer in women 45 years of age or younger

Show Less
1 New Jersey Gynecologic Oncology, PA., Little Silver, New Jersey, USA
Eur. J. Gynaecol. Oncol. 2000, 21(3), 249–250;
Published: 10 June 2000
Abstract

Objective: The clinical characteristics and outcomes of endometrial cancer in women 45 years of age or younger evaluated and treated at the community hospital level are presented. Methods: A series of 500 consecutive women with endometrial cancer operated on by the author over a nine-year period of time was used to identify women 45 years of age or younger and compared to older patients from the author’s data base. Results: Although the majority of patients presented with clinical stage I disease, 30% of women 45 years of age or younger had occult metastatic disease and 5.0% had clear cell or papillary serous histology, similar to the older patient population. In addition, survival was similar in both groups of patients. Serum CA-125 was useful in identifying patients with possible occult metastatic disease in the group of women 45 years old or younger. Conclusion: Patients 45 years of age or younger with uterine cancer are not ipso facto a “lower risk” group of patients; efforts to preserve fertility should be balanced against a thorough effort to identify those individuals at higher risk for occult metastases.

Keywords
Endometrial cancer
Younger patient
Age 45
CA-125
Share
Back to top